UW-Madison study investigating treatment to prevent Alzheimer’s disease
A research study at UW–Madison School of Medicine and Public Health is investigating a drug that could one day prevent Alzheimer’s disease....
17 November, 2023
FDA
Patients still unaware of drug development and clinical trials
A vast majority of people still do not understand the process of drug development unless clinical trials are the only treatment option left, says Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI)....
08 November, 2023
Drugs aren’t required to be tested in people who are obese. Here’s why that’s a problem
More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies. That’s because they are not required to be included in drug studies. And often, they’re explicitly excluded....
07 November, 2023
A landmark gene-editing treatment for sickle cell disease moves closer to reality
The Food and Drug Administration may soon approve a therapy that uses the gene-editing technique called CRISPR to treat sickle cell disease. It would mark the first time gene editing moves from the lab into clinical use....
31 October, 2023
From the Outside In: An Overview of Four Decades of Progress on HIV/AIDS
New clinical treatments for diseases are conceived in a laboratory, then tested on animals or through simulations, and finally studied on human beings if deemed promising enough. Moving from point to point in this cycle is rarely a straight line, and costly and time-consuming trial-and-...
17 October, 2023
FDA Proposes Rule Aimed at Helping to Ensure Safety and Effectiveness of Laboratory Developed Tests
Today, the U.S. Food and Drug Administration announced a proposed rule regarding laboratory developed tests, or LDTs, which play an important role in healthcare. The rule is aimed at helping to ensure the safety and effectiveness of these tests, which are used in a growing...
29 September, 2023
FDA approves new COVID-19 booster shots as Wisconsin sees uptick in cases and hospitalizations
The latest round of COVID-19 vaccines have been approved by the FDA. On Tuesday, the CDC will determine who should get the new shots....
11 September, 2023
Faster drug approvals by FDA raise concerns about transparency and beneficence in clinical trials
Are faster drug approvals by the FDA hurting the public's overall perception of clinical research?...
30 August, 2023
Psychedelic drug trial guidance: Commenters see vital role for psychotherapy
Commenters on the FDA's guidance on clinical investigations and drug development programs for psychedelic drugs raised concerns about decoupling drug administration from psychotherapy support, the proposed credentials for lead safety monitors and the agency’s characterization of the abuse potential of psychedelic drugs....
29 August, 2023
FDA drug approvals: Let us see all the evidence
Clinicians and consumers are deprived of the full picture needed for informed decision-making....
27 August, 2023